Novo Nordisk Postdoctoral Fellowships

Novo Nordisk Postdoctoral Fellowships

Karolinska Institutet (KI)

Stockholm, Sweden

Novo Nordisk Postdoctoral Fellowship Programme at Karolinska Institutet

Overview of the Role

Novo Nordisk is funding a prestigious fellowship programme at Karolinska Institutet for basic science postdoctoral researchers. The programme is focused on research in diabetes and its comorbidities, endocrinology and metabolism. It aims to support the development of a new generation of exceptional young early career diabetes researchers, who will become future leaders in the field, while further developing scientific excellence within diabetes and ultimately improving the lives of patients. As part of this programme, we are looking to recruit 4 outstanding postdoctoral researchers.

Based at Karolinska Institutet, Fellows will undertake in a cutting edge research project, mentored by world-leading researchers in the field of diabetes. In addition, it is anticipated that during the course of the fellowship, fellows will have the opportunity to spend approximately 3 months in the research laboratories at Novo Nordisk in Copenhagen. Thus, Fellows will gain insight into research conducted in both academia and industry. In order to increase coherence around the Fellowship programme, a number of events will be held throughout the year such as high profile lectures, symposia, etc. which the fellows will attend, both at Karolinska Institutet and at Novo Nordisk in Copenhagen.

The fellowships are fully funded with salary for a 3 year period and it is our intention that the fellowships will start in the autumn of 2018, though some flexibility with the start date might be possible.

Research Projects

The following 11 projects are available:

1. Prinicipal Investigator Per-Olof Berggren Project Title Physiological and pathophysiological Ca2+ signaling in pancreatic islet cells. 

2. Principal Investigator Niklas Björkström Project Title Obesity-induced metabolic deregulation of tissue-resident NK cells in the development of fatty liver disease and insulin resistance, a “human multi-organ study”. 

3. Principal Investigators Magnus Bäck and Susanna Larsson Project Title Aortic Valve Stenosis  – an Underestimated Comorbidity in Diabetes Mellitus. 

4. Principal Investigator Sofia Carlsson Project Title LADA-latent autoimmune diabetes in adults, risk factors and prognosis. 

5. Prinicipal Investigator Lisa Juntti-Berggren Project Title Apolipoprotein CIII, a target in the battle against diabetes and its comorbidities. 

6. Prinicipal Investigators Peder Olofsson and Stephen Malin Project Title Neural control of inflammation in non‐alcoholic steatohepatitis and fatty liver disease.

7. Principal Investigators John Pernow and Per Eriksson Project Title The red blood cell as a novel mediator of vascular injury in type 2 diabetes. 

8. Prinicipal Investigators Mikael Rydén and Peter Arner Project Title Identifying the role of human white adipose tissue for the development of cardiovascular complications in type 2 diabetes. 

9. Prinicipal Investigator Kirsty Spalding Project Title Cell regeneration in the healthy and pathological human kidney.

10. Principal Investigator Eckardt Treuter Project Title From co-repressor phosphorylation to epigenome therapy of fatty liver disease. 

11. Principal Investigators Juleen Zierath and Anna Krook Project Title Metabolic crosstalk and the regulation of insulin sensitivity in Type 2 diabetes.   

Full details on each project and contact information for the PI’s can be found at:

The closing date for applications is midnight CEST on Sunday 7th April 2019.

Please apply via recruiter’s website.